Belle Mead Orthodontic Care Pa | |
2139 Route 206 Belle Mead NJ 08502-4010 | |
(908) 874-8360 | |
(908) 874-5985 |
Full Name | Belle Mead Orthodontic Care Pa |
---|---|
Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
Location | 2139 Route 206, Belle Mead, New Jersey |
Authorized Official Name and Position | Frederic C Sterritt (PRESIDENT) |
Authorized Official Contact | 9088748360 |
Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
Mailing Address | Practice Location Address |
---|---|
Belle Mead Orthodontic Care Pa 2139 Route 206 Belle Mead NJ 08502-4010 Ph: (908) 874-8360 | Belle Mead Orthodontic Care Pa 2139 Route 206 Belle Mead NJ 08502-4010 Ph: (908) 874-8360 |
NPI Number | 1063497154 |
---|---|
Provider Enumeration Date | 12/12/2005 |
Last Update Date | 08/22/2020 |
Identifier | Type | State | Issuer |
---|---|---|---|
1063497154 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | 10683NJ (New Jersey) | Primary |
News Archive
Certain pediatric surgeries carry such low risk of serious blood loss that clinicians can safely forgo expensive blood typing and blood stocking before such procedures, suggest the results of a small study by researchers at the Johns Hopkins Children's Center.
YM BioSciences Inc. today announced results of a collaboration with researchers at the University of Toronto for the development of highly potent antibody-radionuclide conjugates for use in the treatment of cancer. The approach has successfully concluded its first series of proof-of-principle experiments establishing promise for future development and application.
Kaiser Health News staff writer Ankita Rao reports: "The buzz, and anxiety, in the medical profession is palpable – trade magazines tout new coping strategies, doctor groups discuss the transformation of practices. Physicians are experimenting with business models and new practice techniques, hoping to find work that is both financially and personally rewarding" (Rao, 5/15).
The largest genomic institute of the world, BGI Shenzhen, China, together with Reproductive & Genetic Hospital CITIC-XIANGYA announced today that they have successfully applied Next Generation Sequencing to detect in vitro fertilized embryos with genetic abnormalities.
GeNO LLC a privately held, advanced development-stage technology company, today announced that the U.S. Food and Drug Administration has granted clearance of its Investigational New Drug application for its stand-alone gas cylinder Nitrosylâ„¢ Delivery Platform.
› Verified 5 days ago